Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04625062 · ClinicalTrials.gov registry record · Phase 1
Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors
A Phase 1 study, sponsored by New York University.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT04625062 is a Phase 1 study that has completed, run by New York University. The registered enrollment target is 7 participants.
The verdict
NCT04625062, a Phase 1 study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study aims to evaluate the relative efficacy of biofeedback and traditional treatment for residual speech errors when both are delivered via telepractice. In a single-case randomization design, up to eight children with RSE will receive both visual-acoustic biofeedback and traditional treatment via telepractice. Acoustic measures of within-session change will be compared across sessions randomly assigned to each condition. It is hypothesized that participants will exhibit a clinically significant overall treatment response and that short-term measures of change will indicate that biofeedback is associated with larger increments of progress than traditional treatment.
Interventions
- BEHAVIORAL Visual-acoustic biofeedback
- BEHAVIORAL Motor-based treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2021-03-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04625062
The ClinicalTrials.gov registry entry for NCT04625062 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Visual-acoustic biofeedback is the first listed.
NCT04625062 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04625062 about?
NCT04625062 is a clinical study titled "Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors". This study aims to evaluate the relative efficacy of biofeedback and traditional treatment for residual speech errors when both are delivered via telepractice. In a single-case randomization design, up to eight children with RSE will receive both visual-acoustic biofeedback and traditional treatment...
What is the current status of trial NCT04625062?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2020-09-01. Estimated completion is 2021-03-18.
What interventions are being tested in trial NCT04625062?
The interventions under investigation include: Visual-acoustic biofeedback (BEHAVIORAL), Motor-based treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04625062?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.